Corneal cross linking for keratoconus.

Anne Keating, Roberto Pineda, Kathryn Colby

Journal: Seminars in ophthalmology 2011;25(5-6):249-55

PMID: 21091008

Abstract

Riboflavin-induced ultraviolet light (UV) cross linking has received a significant amount of attention in recent years. It is currently approved in Europe as a treatment for keratoconus and is also being used for other corneal disorders. The goal of this paper is to review in detail seminal papers and studies that have been done to support cross linking as a safe and effective treatment for patients with early stages of keratoconus.

Address: Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA. [email protected]

DOI: 10.3109/08820538.2010.518503

Link outs

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.3109/08820538.2...

MeSH Terms: Collagen, Corneal Stroma, Cross-Linking Reagents, Humans, Keratoconus, Photochemotherapy, Photosensitizing Agents, Riboflavin, Ultraviolet Rays